Altamira Therapeutics Ltd
(FRA:2QA)
€
948
0 (0%)
Market Cap: 2.29 Mil
Enterprise Value: 1.75 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 34/100 Altamira Therapeutics Ltd (FRA:2QA) Transcripts
- Full Year 2023 Altamira Therapeutics Ltd Earnings Call TranscriptApr 10, 2024€948Earnings
- Altamira Therapeutics Ltd to Host Investor & Business Update Call TranscriptDec 11, 2023
- Half Year 2023 Altamira Therapeutics Ltd Earnings Call TranscriptSep 12, 2023€948Earnings
- Q4 2022 Altamira Therapeutics Ltd Earnings Call TranscriptMay 16, 2023€948Earnings
- Altamira Therapeutics Ltd Business Update Conference Call TranscriptSep 14, 2022
- Q4 2021 Altamira Therapeutics Ltd Earnings Call TranscriptApr 12, 2022€948Earnings
- Altamira Therapeutics Ltd To Discuss Business Update Bentrio TM TranscriptSep 27, 2021
- Auris Medical Holding Ltd Acquires RNA Therapeutics Company - M&A Call TranscriptJun 03, 2021
- Q4 2020 Auris Medical Holding Ltd Earnings Call TranscriptApr 13, 2021€1346.4 (-14.83%)Earnings
- Half Year 2020 Auris Medical Holding Ltd Earnings Call TranscriptSep 17, 2020€266 (+3.91%)Earnings
- Q4 2019 Auris Medical Holding Ltd Earnings Call TranscriptApr 16, 2020€296 (-1.99%)Earnings
- Q2 2019 Auris Medical Holding Ltd Earnings Call TranscriptAug 15, 2019€912.4 (-2.73%)Earnings
- 1